These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2565250)

  • 41. [Complement levels of rat sera during the course of adjuvant arthritis].
    Cho S; Miki H; Hasegawa O; Okitsu K
    Ryumachi; 1984 Apr; 24(2):80-6. PubMed ID: 6332385
    [No Abstract]   [Full Text] [Related]  

  • 42. A novel non-polyglutamable anti-folate, MX-68, inhibits the induction of experimental autoimmune uveitis in rats.
    Hiraoka M; Mihara M; Takeda Y; Miyasaka N
    Exp Eye Res; 1998 Jul; 67(1):1-8. PubMed ID: 9702173
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The failure of long term effect of cyclophosphamide on systemic immunologic connective tissue disease in rabbit.
    Brouilhet H; Rabaud M; Kahan A; Piatier D
    J Med; 1978; 9(6):483-9. PubMed ID: 287763
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effects of a high dose of vitamin A on experimental immunologic arthritis].
    Devulder B; Plouvier B; Wattre P; Tacquet A; Ferrando R
    Int J Vitam Nutr Res; 1976; 46(3):322-9. PubMed ID: 977218
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 6-Sulfanilamidoindazole arthritis of the rat: complement activity and sulfhydryl group concentration of the serum in three different phases of inflammation.
    Hirschelmann R; Stelzner A; Bekemeier H; Elger J
    Z Rheumatol; 1976; 35(11-12):403-6. PubMed ID: 1007637
    [TBL] [Abstract][Full Text] [Related]  

  • 46. On the possible anti-rheumatic effects (immuno-effector?)of imidazole derivatives (levamisole, clotrimazole, niridazole).
    Delbarre F
    Biomedicine; 1977 Apr; 27(3):97-8. PubMed ID: 556383
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The effects of levamisol and thymosterin b on adjuvant disease in rats (author's transl)].
    Grimová J; Korcáková L; Rovenský J; Trnavský K
    Cas Lek Cesk; 1977 Jul; 116(28):882-5. PubMed ID: 902294
    [No Abstract]   [Full Text] [Related]  

  • 48. Analysis of dimethyl sulfoxide immunosuppression in the rat model of collagen II autoimmune arthritis: an effect dependent upon intraperitoneal administration and associated with toxicity.
    Watson WC; Pucevich CL; Cremer MA; Pinals RS; Townes AS
    Agents Actions; 1985 Oct; 17(1):84-8. PubMed ID: 4083183
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prolonged treatment with D-penicillamine: effects on adjuvant arthritis in the rat.
    Dunn CJ; Prouteau M; Delahaye M; Purcell T; Branceni D
    Agents Actions; 1984 Feb; 14(2):269-73. PubMed ID: 6711389
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Complement activation and inhibition in experimental models of arthritis.
    Linton SM; Morgan BP
    Mol Immunol; 1999; 36(13-14):905-14. PubMed ID: 10698345
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Elevated levels of serum hyaluronate and correlation with disease activity in experimental models of arthritis.
    Björk J; Kleinau S; Tengblad A; Smedegård G
    Arthritis Rheum; 1989 Mar; 32(3):306-11. PubMed ID: 2564780
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The evaluation of natural substances in the treatment of adjuvant arthritis.
    Hanley DC; Solomon WA; Saffran B; Davis RH
    J Am Podiatry Assoc; 1982 Jun; 72(6):275-84. PubMed ID: 7086049
    [No Abstract]   [Full Text] [Related]  

  • 53. Inhibition of the immune response by rapamycin, a new antifungal antibiotic.
    Martel RR; Klicius J; Galet S
    Can J Physiol Pharmacol; 1977 Feb; 55(1):48-51. PubMed ID: 843990
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The arthritic pathologies accompanying primary immunodeficiencies with antibody synthesis disturbances].
    Swierkot J; Lewandowicz-Uszyńska A; Jankowski A; Szechiński J
    Postepy Hig Med Dosw (Online); 2005 May; 59():219-23. PubMed ID: 15928606
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Preventive and therapeutic effect of estrogen administration in adjuvant arthritis].
    Schlaghecke R; Lenhardt E; Fortkamp E; Juli E; Zeidler H
    Z Rheumatol; 1989; 48(6):313-6. PubMed ID: 2623977
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of tryptophane, anthranilic acid and ribonucleic acid on adjuvant arthritis.
    Forst MB; Davis RH
    J Am Podiatry Assoc; 1979 Nov; 69(11):643-56. PubMed ID: 501019
    [No Abstract]   [Full Text] [Related]  

  • 57. Treatment of adjuvant arthritis with nonsteroidal agents. A comparative study.
    Rand SA; Forst MB
    J Am Podiatry Assoc; 1980 Feb; 70(2):65-72. PubMed ID: 7372996
    [No Abstract]   [Full Text] [Related]  

  • 58. Azathioprine treatment of adjuvant arthritis.
    Vinegar R; Truax JF; Selph JL; Lea A; Johnston PR
    J Immunopharmacol; 1979; 1(4):497-520. PubMed ID: 401318
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Studies on the chronic phase of adjuvant arthritis: effect of SR 41319, a new diphosphonate.
    Barbier A; Breliére JC; Remandet B; Roncucci R
    Ann Rheum Dis; 1986 Jan; 45(1):67-74. PubMed ID: 3754110
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inefficacy of thalidomide on rat adjuvant-induced arthritis and lack of arthrogenicity of Hansen bacilli.
    Tsutsumi S; Gidoh M
    Nihon Rai Gakkai Zasshi; 1988; 57(3):122-8. PubMed ID: 3074967
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.